{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:37:31Z","timestamp":1791020251175,"version":"4.1.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2011,2,10]],"date-time":"2011-02-10T00:00:00Z","timestamp":1297296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Many medications used to control blood pressure have been associated with bone metabolism. In addition, hypertension itself may be associated with reduced bone mineral density. We examined the relative risk of fracture among subjects with hypertension initiating single-drug therapy for antihypertension treatment. We assembled a large cohort of Medicare beneficiaries with a diagnosis of hypertension who had not filled a prescription for an antihypertensive medication in the prior 365 days. All subsequently began treatment with a single antihypertensive drug. These subjects were followed forward using health care utilization data to determine the risk of a typical osteoporotic fracture. Adjusted Cox proportional hazards regression models were constructed to assess the relative risk of fracture across types of antihypertensive medications. We identified 376,061 eligible subjects. Fracture rate in the total cohort was 35.2 per 1000 person-years [95% confidence interval (CI) 34.4\u201336.1]. Rates varied significantly across type of antihypertensive, with thiazide diuretics having the lowest rate (28.5, 95% CI 25.4\u201331.9) and loop diuretics the highest rate (49.0, 95% CI 46.1\u201352.1). In models adjusting for relevant comorbidities and comedications accessible in health care utilization data, the risk of fracture was reduced in users of angiotensin receptor blockers [hazard ratio (HR)\u2009=\u20090.76, 95% CI 0.68\u20130.86) and thiazide diuretics (HR\u2009=\u20090.85, 95% CI 0.76\u20130.97) compared with calcium channel blockers. The adjusted fracture risk was not significantly different from the reference for loop diuretics, beta blockers, and angiotensin-conversting enzyme (ACE) inhibitors. It is concluded that the risk of fracture differs across users of different antihypertensive medications. \u00a9 2011 American Society for Bone and Mineral Research.<\/jats:p>","DOI":"10.1002\/jbmr.356","type":"journal-article","created":{"date-parts":[[2011,2,10]],"date-time":"2011-02-10T23:52:21Z","timestamp":1297381941000},"page":"1561-1567","source":"Crossref","is-referenced-by-count":104,"title":["Risk of fractures in older adults using antihypertensive medications"],"prefix":"10.1093","volume":"26","author":[{"given":"Daniel H","family":"Solomon","sequence":"first","affiliation":[{"name":"Divisions of Rheumatology and Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Mogun","sequence":"additional","affiliation":[{"name":"Divisions of Rheumatology and Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Garneau","sequence":"additional","affiliation":[{"name":"Divisions of Rheumatology and Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Fischer","sequence":"additional","affiliation":[{"name":"Divisions of Rheumatology and Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,2,10]]},"reference":[{"key":"2024020318022478700_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.HYP.0000252676.46043.18","article-title":"Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004","volume":"49","author":"Ong","year":"2007","journal-title":"Hypertension."},{"key":"2024020318022478700_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM199808063390607","article-title":"Diuretic therapy","volume":"339","author":"Brater","year":"1998","journal-title":"N Engl J Med."},{"key":"2024020318022478700_bib3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0092-8674(02)01049-8","article-title":"Leptin regulates bone formation via the sympathetic nervous system","volume":"111","author":"Takeda","year":"2002","journal-title":"Cell."},{"key":"2024020318022478700_bib4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0895-7061(03)00845-8","article-title":"Effect of quinapril, quinapril-hydrochlorothiazide, and enalapril on the bone mass of hypertensive subjects: relationship with angiotensin converting enzyme polymorphisms","volume":"16","author":"Perez-Castrillon","year":"2003","journal-title":"Am J Hypertens."},{"key":"2024020318022478700_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1359\/jbmr.0301214","article-title":"Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study","volume":"19","author":"Pasco","year":"2004","journal-title":"J Bone Miner Res."},{"key":"2024020318022478700_bib6","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/jama.292.11.1326","article-title":"Use of beta-blockers and risk of fractures.[see comment]","volume":"292","author":"Schlienger","year":"2004","journal-title":"JAMA."},{"key":"2024020318022478700_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.blo.0000200242.52802.6d","article-title":"Beta-blockers increase bone mineral density","volume":"443","author":"Turker","year":"2006","journal-title":"Clin Orthop Relat Res."},{"key":"2024020318022478700_bib8","first-page":"337","article-title":"A longitudinal study of total and regional bone mineral content and biochemical markers of bone resorption in patients with idiopathic hypercalciuria on thiazide treatment","volume":"19","author":"Rico","year":"1993","journal-title":"Miner Electrolyte Metab."},{"key":"2024020318022478700_bib9","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/bmj.301.6764.1303","article-title":"Effect of thiazide on rates of bone mineral loss: a longitudinal study","volume":"301","author":"Wasnich","year":"1990","journal-title":"BMJ."},{"key":"2024020318022478700_bib10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archinte.168.7.735","article-title":"Loop diuretic use and increased rates of hip bone loss in older men: the Osteoporotic Fractures in Men Study","volume":"168","author":"Lim","year":"2008","journal-title":"Arch Intern Med."},{"key":"2024020318022478700_bib11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/jbmr.5650080604","article-title":"Determinants of bone mineral density and risk factors for osteoporosis in healthy elderly women","volume":"8","author":"Ooms","year":"1993","journal-title":"J Bone Miner Res."},{"key":"2024020318022478700_bib12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2796.2004.01434.x","article-title":"Effects of long-term treatment with loop diuretics on bone mineral density, calcitropic hormones and bone turnover","volume":"257","author":"Rejnmark","year":"2005","journal-title":"J Intern Med."},{"key":"2024020318022478700_bib13","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00198-007-0354-8","article-title":"Beta-blocker use and risk of fractures in men and women from the general population: the MONICA\/KORA Augsburg cohort study","volume":"18","author":"Meisinger","year":"2007","journal-title":"Osteoporos Int."},{"key":"2024020318022478700_bib14","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.bone.2007.01.006","article-title":"Protective effect of beta blockers in postmenopausal women: influence on fractures, bone density, micro and macroarchitecture","volume":"40","author":"Bonnet","year":"2007","journal-title":"Bone."},{"key":"2024020318022478700_bib15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.hjh.0000203845.26690.cb","article-title":"Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study","volume":"24","author":"Rejnmark","year":"2006","journal-title":"J Hypertens."},{"key":"2024020318022478700_bib16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/JBMR.041202","article-title":"beta-Blocker use, BMD, and fractures in the study of osteoporotic fractures","volume":"20","author":"Reid","year":"2005","journal-title":"J Bone Miner Res."},{"key":"2024020318022478700_bib17","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/pds.1318","article-title":"Use of beta-2 agonists and risk of hip\/femur fracture: a population-based case-control study","volume":"16","author":"de Vries","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"2024020318022478700_bib18","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1532-5415.2005.53178_7.x","article-title":"Beta-blocker use, bone mineral density, and fracture risk in older women: results from the Epidemiologie de l'Osteoporose prospective study","volume":"53","author":"Levasseur","year":"2005","journal-title":"J Am Geriatr Soc."},{"key":"2024020318022478700_bib19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00223-004-0222-x","article-title":"Fracture risk in perimenopausal women treated with beta-blockers","volume":"75","author":"Rejnmark","year":"2004","journal-title":"Calcif Tissue Int."},{"key":"2024020318022478700_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00223-008-9198-2","article-title":"Hypertension is a risk factor for fractures","volume":"84","author":"Vestergaard","year":"2009","journal-title":"Calcif Tissue Int."},{"key":"2024020318022478700_bib21","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol."},{"key":"2024020318022478700_bib22","article-title":"WHO Center for Drug Statistics Methodology","author":"Organization","year":"2008","journal-title":"World Health Organization."},{"key":"2024020318022478700_bib23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0895-4356(92)90047-Q","article-title":"Identification of fractures from computerized Medicare files","volume":"45","author":"Ray","year":"1992","journal-title":"J Clini Epidemiol."},{"key":"2024020318022478700_bib24","first-page":"541","article-title":"Internal validation of Medicare claims data.[see comment]","volume":"5","author":"Baron","year":"1994","journal-title":"Epidemiology."},{"key":"2024020318022478700_bib25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clini Epidemiol."},{"key":"2024020318022478700_bib26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jclinepi.2004.10.012","article-title":"A review of uses of health care utilization databases for epidemiologic research on therapeutics","volume":"58","author":"Schneeweiss","year":"2005","journal-title":"J Clini Epidemiol."},{"key":"2024020318022478700_bib27","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1096\/fj.07-098954","article-title":"Angiotensin II accelerates osteoporosis by activating osteoclasts","volume":"22","author":"Shimizu","year":"2008","journal-title":"FASEB J."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.356","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/26\/7\/1561\/56558559\/356_ftp.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/26\/7\/1561\/56558559\/356_ftp.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:02:29Z","timestamp":1710342149000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/26\/7\/1561-1567\/7598044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,10]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2011,2,10]]},"published-print":{"date-parts":[[2011,7,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.356","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,7,1]]},"published":{"date-parts":[[2011,2,10]]}}}